MedPath

The Comparison Between the PVAM and CPVI for the Patients of PAF

Not Applicable
Completed
Conditions
Atrial Fibrillation
Pulmonary Vein Isolation
Registration Number
NCT03026413
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Brief Summary

To compare the efficacy and safety of circumferential pulmonary vein isolation without contact force with the pulmonary vein antrum modification for patients of paroxysmal atrial fibrillation.

Detailed Description

This is a single centre, prospective control study. The study will enroll 180 patients with 2:1 grouped.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
180
Inclusion Criteria
  • patients with paroxysmal atrial fibrillation refractory to drugs
  • with consent
Exclusion Criteria
  • LVEF<50%
  • history of cardiac surgery
  • valvular heart disease
  • abnormal thyroid function
  • left atrial thrombus

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
any recorded atrial arrhythmias proved by 7-day holterat least 18 months follow up

sustained at least 30s

Secondary Outcome Measures
NameTimeMethod
procedure timetime during patient enrollment

time that the patient spend in the procedure room

x ray timetime during patient enrollment

x ray spent during the procedure

adverse eventat least 18 months follow up

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.